03 Nov 2022 14:07 CET

Issuer

SoftOx Solutions AS

Oslo, Norway, November 3, 2022: Geir H. Almås, CEO of SoftOx Solutions AS, a
person discharging managerial responsibilities in SoftOx Solutions AS (the
“Company”), has notified the Company of a transfer of a part of the convertible
loan issued by the Company, as announced on October 11 2022.

Please refer to the attached form for further details about the transfer.

For further information, please contact:
CEO Geir Almås of SoftOx Solutions AS, or
CFO Kristine Rød of SoftfOx Solutions AS
Mail: ir@soft-ox.com
Mobile: (+47) 948 59 599

The information included in this announcement is defined as inside information
pursuant to MAR article 7, and is publicly disclosed in accordance with MAR
article 17. The announcement is made by the contact person.

About SoftOx Solutions AS
SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a Norwegian
biopharmaceutical and MedTech company based in Oslo, with the goal of reducing
the spread of infection and emergence of antimicrobial resistance. For more
information on SoftOx, visit www.soft-ox.com


574708_Melding om transaksjoner utført av personer med ledelsesansvar (primærinnsidere) og deres nærsta°ende (KRT-1500).pdf

Source

SoftOx Solutions AS

Provider

Oslo Børs Newspoint

Company Name

SOFTOX SOLUTIONS

ISIN

NO0010811961

Symbol

SOFTX

Market

Euronext Growth